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Abstract—Skin lesions are conditions that appear on a patient
due to many different reasons. One of these can be because
of an abnormal growth in skin tissue, defined as cancer. This
disease plagues more than 14.1 million patients and had been
the cause of more than 8.2 million deaths, worldwide. Therefore,
the construction of a classification model for 12 lesions, including
Malignant Melanoma and Basal Cell Carcinoma, is proposed.
Furthermore, in this work, it is used a ResNet-152 architecture,
which was trained over 3,797 images, later augmented by a factor
of 29 times, using positional, scale, and lighting transformations.
Finally, the network was tested with 956 images and achieve an
area under the curve (AUC) of 0.96 for Melanoma and 0.91 for
Basal Cell Carcinoma.
Index Terms—optical imaging, skin, neural network
I. INTRODUCTION
Today, skin cancer is a public health and economic issue,
that for long years have been approached with the same
methodology by the dermatology field [1]. This is troublesome
when we analyze that for the last 30 years the numbers of cases
diagnosed with skin cancer have increased significantly [2].
It is more troublesome when money comes in the equation,
seeing that millions of dollars are being spent in the public
sector [3]. A major part of this is spent in the individual
analysis of the patient. Where the doctor analyzes the lesion
and takes action on the pieces of evidence seen. If any of
these steps were to be optimized, it could mean a decrease in
expenditure for the whole dermatology sector.
Dermatology is one of the most important fields of
medicine, with the cases of skin diseases outpacing hyperten-
sion, obesity and cancer summed together. That is accounted
because skin diseases are one of the most common human ill-
ness, affecting every age, gender and pervading many cultures,
summing up to between 30% and 70% of people in the United
States. This means that in any given time at least 1 person,
out of 3, will have a skin disease [4]. Therefore, skin diseases
are an issue on a global scale, positioning on 18th in a global
rank of health burden worldwide [5].
Furthermore, medical imaging can show itself as a resource
of high value, as dermatology has an extensive list of illness
that it has to treat. In addition, the field has developed its
* The author is a member of the “Machine Learning Research Group” from
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own vocabulary to describe these lesions. However, verbal
descriptions have their limitations and a good picture can
replace successfully many sentences of description and is not
susceptible to the bias of the message carrier.
In addition, the recommended way to detect early skin
diseases is to be aware of new or changing skin growths [6].
Analysis with the naked eye is still the first resource used
by specialists, along with techniques such as ABCDE, that
consists of scanning the skin area of interest for asymmetry,
border irregularity, uniform colors, large diameters and evolv-
ing patches of skin over time [7]. In this way, the analysis
from medical images is analogous to the analysis with the
naked eye and thus can be applied the same techniques and
implications. This supports the idea that skin cancer often is
detectable through naked eye and medical photography.
Worldwide the most common case of cancer is skin cancer,
been melanoma, basal and squamous cell carcinoma (BCC and
SCC) the most frequent types of the disease [8]. This type of
the disease is most frequent in countries with the population
with predominant white skin or in countries like Australia or
New Zealand [9].
In Brazil, it is estimated that for the biennium of 2018-2019,
there will be 165,580 new cases of non-melanoma skin cancer
(BCC and SCC mostly) [10]. Moreover, it is visible that the
incidence of these types of skin cancer had risen for many
years. This increase can be due to the combination of various
factors, such as longer longevity of the population, more
people being exposed to the sun and better cancer detection
[8].
In the United States, the numbers add up to 9,730 deaths
estimated for 2017 [6]. Skin cancer accounts for more than
1,688,780 cases (not including carcinoma in situ, nor non-
melanoma cancers) in the US alone in the year of 2017 [6].
Despite skin cancer being the most common type of cancer
in society, it does not represent a great death rate in its first
stages, since the patient has a survival rate of 97%. However,
if the patients are diagnosed in the later stages the 5-year
survival rate decreases to 15%.
In Brazil, were expected to occur 114,000 new cases of non-
melanoma skin cancer in 2010. From that, it was expected that
95% were diagnosed in early stages. However, even with early
diagnosis this amount of cases means around R$37 million
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(Reais) to the health public system and R$26 million to the
private system per year [3].
Moreover, we can divide skin lesions into two major groups,
one being malignant lesions and the other benign lesions. The
first is composed mostly of skin cancers and the latter being
composed of any lesion that does not pose a major threat.
One counterexample of this division is the actinic keratosis,
that presents itself as a potential SCC, as it has the potential
to develop into it. Thus, actinic keratosis is classified as a
precancerous lesion [11]. Furthermore, this work analyzed and
chose 12 lesions in total, 4 malignant and 8 benign (being 1
precancerous), as seen on Figure 1. The lesions where chosen
mainly on the public data available online, to be described in
subsection III-A.
Seeing the problems involved in diagnosing skin lesions,
this work envisions to create a learning model to classify skin
lesions in one of 12 conditions of interest. With this purpose,
the classifier aims to correct distinguish lesions analyzing
clinical images with the condition. Furthermore, this can prove
to be a useful tool to aid patients and doctors on a daily basis
operation.
Furthermore, this work is done with the vision of being
the stepping stone for newer approaches that democratize and
distribute access to health care. A good lesion classification
model may be the motor that will accelerate the construction
of tools that puts the possibility of early diagnosis and alert on
patient‘s hands, even far isolated patients, where few doctors
can reach. These tools may save many lives and reduce several
costs with the treatment of late-stage diseases.
The related work in this field proved that there are many
algorithms capable of tackling this problem, but there is an
astonishing difference between shallow and deep methods in
machine learning. With that in view, this work will guide
its efforts in using deep neural networks to achieve its main
objective. For this to happen, the gathering of good practices
and techniques used to approach the classification of clinical
images is needed.
II. RELATED WORK
Many algorithms and tools have been created to aid these
professionals in their task of detecting diseases in many
fields [12, 13, 14, 15, 16]. This has proven to add more
reliability and confidence to doctors in their practices as they
have more information to diagnose patients. For dermatology
and skin lesions detection has not been different. History
shows that many approaches had been made over the course
of years, applications with shallow algorithms such as K-
Nearest Neighbors (KNN) [17] and Support Vector Machines
(SVM) [18] had been proven to accomplish good results, but
are as well tiresome to build applications that involve such
approaches.
Seeing this, some researchers have been applying this ap-
proach to classifying skin lesions with success. One common
thing in this domain is the lack of quality and scarcity of open
data. It is common to see works with only a couple hundred of
examples. That is a characteristic of the medical field. There
are many hospitals and clinics that hold huge amounts of data
and do not make it public mainly because of privacy issues
with patients. However, many authors still apply efforts to
push forward the technology in such fields, overcoming these
barriers. For the purposes of this work, we listed some related
researches that uses deep learning in dermatology, applying
neural networks to skin lesions.
Matsunaga et al. (2017) proposed an approach to classify
melanoma, seborrheic keratosis, and nevocellular nevus, using
dermoscopic images. In their work, they proposed an ensemble
solution with two binary classifiers, that still leveraged from
age and sex information of the patients, if they were available.
Furthermore, they utilized techniques of data augmentation,
using a combination of 4 transformations (rotation, translation,
scaling and flipping). For the architecture, they chose the
ResNet-50 implementation on the framework Keras, with
personal modifications. This model was pre-trained with the
weights for a generic object recognition model and finally used
two optimizers AdaGrad and RMSProp. This work was then
submitted to the ISBI Challenge 2017 and won first place,
ahead of other 22 competitors.
Nasr-Esfahani et al. (2016) showed a technique that uses
imaging processing as a previous step before training. This re-
sult in a normalization and noise reduction on the dataset, since
non-dermoscopic images are prone to have non-homogeneous
lightning and thus present noise. Moreover, this work utilizes
a pre-processing step using k-means algorithm to identify the
borders of a lesion and extract a binary mask, which the lesion
is present. This is done to minimize the interference of the
healthy skin in the classification. Furthermore, Nasr-Esfahani
et al. (2016) used a technique called data augmentation to
increase the dataset, using three transformations (cropping,
scaling and rotation) and multiplied the dataset by a factor of
36 times. Finally, a pre-trained convolutional neural network
(CNN) is used to classify between melanoma and melanocytic
nevus for 200 epochs (20,000 iterations, using a batch size of
64 and a dataset with 6,120 examples).
Menegola et al. (2017) presented a thorough study for
the 2017 ISIC Challenge in skin-lesion classification. In this
work, it is presented experimentations with some pre-trained
deep-learning models on ImageNet for a three-class model
classifying melanoma, seborrheic keratosis, and other lesions.
Models such as ResNet-101 and Inception-v4 were vastly ex-
perimented with several configurations of the dataset, utilizing
6 data sources for the composition of the final dataset. It was
also reported the use of data-augmentation with at least 3
different transformations (cropping, flipping, and zooming).
Also, it is reported that the points that were critical to the
success of the project were mainly due to the volume of data
gathered, normalization of the input images and utilizing meta-
learning. The latter is elucidated as an SVM layer in the final
output of the deep-learning models, that map the outputs to
the three classes that were proposed in the challenge. Finally,
this work won the first place in the 2017 ISIC Challenge for
skin lesion classification.
Kwasigroch et al. (2017) present a solution similar to the
Fig. 1: Skin lesions groups.
Source: Authors.
previous 3. This is due to the inherent limits and problems that
are existent in this domain, data scarcity. In this work transfer-
learning is applied, using two different learning models, VGG-
19 and ResNet-50, both pre-trained on ImageNet 1,000 classes
dataset. These were used to classify between malignant and
benign lesions, using 10,000 dermoscopic images. For the
correct learning process, it was also used the up-sampling
of the underrepresented class. This process was done using
a random number of transformations, chosen between ro-
tation, shifting, zooming, and flipping. Furthermore, in this
paper, it was presented 3 experiments, first with the VGG-
19 architecture with the addition of two extra convolutional
layers, two fully connected layers, and one neuron with a
sigmoid function. Second it experimented with the ResNet-50
model, and finally a implementation of VGG-19 with an SVM
classifier as the fully-connected layer. As a final result, the
modified implementation of the VGG-19 had the best results.
However, the main reason for the poor results in the ResNet-
50 model was due to the small amount of training data. Maybe
with larger amounts of data, it would be possible to train a
small model and produce better results.
Esteva et al. (2017) presented a major breakthrough in the
classification of skin lesions. This research compared the result
of the learning model with 21 board-certified dermatologists
and proven to be more accurate in this task. It was performed
to classify clinical images, indicating whether a lesion is a
benign or malignant one. For this result were used 129,450
images, consisting of 2,032 different diseases and including
3,372 dermoscopic images. Furthermore, it was used a data-
augmentation approach to mitigate problems as variability in
zoom, angle, and lighting present in the context of clinical
images. The augmentation factor was by 720 times, using rota-
tion, cropping, and flipping. Here, an Inception-v3 pre-trained
model was utilized as the main classifier, fine-tuning every
layer and training the final fully connected layer. Moreover,
the training was done for over than 30 epochs using a learning
rate of 0.001, with a decay of 16 after every 30 epochs. The
classification was done in such a way that the model was
trained to classify between 757 fine-grained classes, and then
as the probabilities were predicted it was fed into an algorithm
that selected the two different classes (malignant or benign).
Using this approach, this work achieved a new state of the art
result.
Seog Han et al. (2018) proposed to classify the skin lesions
as unique classes, not composing meta-classes such as benign
and malignant. It used the ResNet-152 pre-trained on the Ima-
geNet model to classify 12 lesions. However, for training was
used other 248 additional classes, that were added to decrease
the false positive and improve the analysis of the middle layers
of the model. Furthermore, this was done in such a way that
the train sampling for the 248 diseases did not outgrow the
main 12, thus when used for inference the model predicted one
of the 12 illness, even when the lesion does not belong to one
of them. For training was used 855,370 images, augmented
approximately 20 to 40 times, using zooming and rotation.
These images were gathered from two Korean hospitals, two
publicly available and biopsy-proven datasets, and one dataset
constructed from 8 dermatologic atlas websites. Furthermore,
the training lasted for 2 epochs using a batch size of 6 and a
learning rate of 0.0001 without decay before 2 epochs. This
early stopping was done to avoid overfitting on the dataset.
Finally, it was reported that the ethnic differences presented
in the context were responsible for poor results in different
datasets, thus it was necessary to gather data from different
ethnics and ages to correct mold the solution to reflect the
real world problem present in skin lesions classification.
Finally, we can observe that every one of these works has
one aspect in common, data scarcity. This is a characteristic
of the medical domain, there are very few annotated examples
of data that are publicly available. The works that proven
to have more impact had to collect data from other sources,
mainly private hospitals or clinics. Furthermore, this step of
data collection did not fully mitigate the problem, it was still
necessary to use techniques such as transfer-learning [24, 25]
and data-augmentation [26, 27, 28].
III. METHODS AND MATERIALS
A. Datasets
Due to the scarcity of data present in the medical field,
the datasets chosen were not the selection of the best on a
collection of options. The process of choosing one mainly took
into account the criterion of public availability. Aside from
that, the only pre-requisite was that the dataset was composed
with only clinical images (photos taken from cameras without
other tools or distorting lenses).
From these criteria, only two datasets fitted the description.
The datasets contained 10 (ten) distinct lesions, containing 4
malignant illnesses at maximum. Another additional dataset
was gathered from dermatologic websites, using a script for
scrapping pages. The latter dataset was acquired from the work
of Seog Han et al. (2018) and is not publicly available due to
copyrights owned by the websites. Finally, these datasets are
further discussed below.
MED-NODE: The first dataset used is provided by the
Department of Dermatology at the University Medical Center
Groningen (UMCG) [29]. This dataset contains 170 images
that are divided between 70 melanoma and 100 nevus cases.
Furthermore, these images were processed with an algorithm
for hair removal.
Edinburgh: The second dataset is provided by the Edin-
burgh Dermofit Image Library [17] and is publicly available
for purchase, under an agreement with the license of use1.
This dataset is the more complete one found on the web.
It contains 1,300 images, that are divided into 10 lesions,
including melanoma, BCC, and SCC. These images are all
diagnosed based on experts opinions. In addition, it is also
provided the binary segmentation of the lesion, for each one.
It is valid to note that the images are not all in the same size.
Furthermore, the lesions and its respective numbers are
listed in the table I.
TABLE I: Lesion sampling for Edinburgh dataset.
Lesion Type Number of images
Actinic Keratosis 45
Basal Cell Carcinoma 239
Melanocytic Nevus (mole) 331
Seborrhoeic Keratosis 257
Squamous Cell Carcinoma 88
Intraepithelial Carcinoma 78
Pyogenic Granuloma 24
Haemangioma 97
Dermatofibroma 65
Malignant Melanoma 76
TOTAL 1,300
Atlas: This last dataset, was acquired from running several
scripts for scrapping different dermatological websites2. So
that is the reason that this dataset was baptized as Atlas. This
dataset was obtained from Seog Han et al. (2018) in a personal
submitted request. It contains 3,816 images downloaded from
websites and distributed between six lesions.
1Available at https://licensing.eri.ed.ac.uk/i/software/
dermofit-image-library.html.
2These websites included, http://dermquest.com, http://www.dermatlas.net,
http://www.dermis.net/dermisroot/en/home/index.htm, http://www.meddean.
luc.edu/lumen/MedEd/medicine/dermatology/melton/atlas.htm, http:
//www.dermatoweb.net, http://www.danderm-pdv.is.kkh.dk/atlas/index.html,
http://www.atlasdermatologico.com.br, http://www.hellenicdermatlas.com/en.
The difference from the Edinburgh dataset is that this
contains two lesions that are not present on the first, Wart and
Lentigo – both benign lesions –, as it can be seen on table
II. This, alongside with the Atlas and MED-NODE datasets,
sums up to 12 lesions, that are the interest of this work.
TABLE II: Lesion sampling for Atlas dataset.
Lesion Type Number of images
Basal Cell Carcinoma 1,561
Lentigo 69
Malignant Melanoma 228
Melanocytic nevus (mole) 626
Seborrheic keratosis 897
Wart 435
TOTAL 3,816
One difference between Atlas and the first two datasets is
the quality of the images, since the dataset was collected from
web pages, is not all images that present the same quality,
nor the same common viewpoints observed on the Edinburgh
dataset. Therefore, this dataset is the most heterogeneous in
matters of quality of imaging, viewpoints, the age of patients
and ethnicity. However, this dataset in its entirety is not
officially diagnosed by specialists, but on the other hand, these
photos were displayed on websites that are reliable and used
by students. So, there is a heuristic that these images were
revised before putting to display in these websites and can be
trusted.
B. Handling data scarcity
As noted previously, for the correct generalization of the
weights and biases of a network, a huge amount of data
is needed. However, the medical field lacks this amount of
images and if only used the data public provided, a good
generalization of the problem cannot be met if we wish to
train a deep neural network.
1) Transfer Learning: In practice, the domains that are
faced in the industry, rather than the academia, usually have
low numbers of labeled data. This poses a major obstacle to
train a deep convolutional neural network from scratch, since
the data may not demonstrate a true representation of the real
world. Thus, it is common to see works that utilize the pre-
trained weights of a previously trained architecture, this can
lead to 2 major approaches.
The approaches are: using a CNN as a fixed feature extractor
or fine-tuning the trained model. The first is mostly used to
collect features of images and then use them to train a linear
classifier in a new dataset. The second strategy is to continue
the training of the network, replacing completely the final
layer, but updating the parameters through backpropagation.
A common use of transfer in computer vision, more specif-
ically object classification, is to use pre-trained models that
were trained on the ImageNet dataset. Some recent work done
by Kornblith et al. (2018) shows that ResNets take the lead
in performance when treated as feature extractors. While only
fine-tuning some models to other datasets, they achieved a new
state-of-the-art. All these tests used pre-trained weights and
fine-tuned them with Nesterov momentum for 19,531 steps,
which sometimes corresponded as more than 1,000 epochs
using a batch size of 256. Finally, it was proven, empirically,
that the Inception-v4 architecture achieves overall better results
for this task than the other 12 pre-trained classification models.
Therefore, transfer learning optimizes and cuts short most
of the time in the training of new applications. However, this
can add some constraints to the work. One example of this is
when using a pre-trained network is not possible to extract and
change arbitrarily the layers of the network. Another point is
that normally, small learning rates are applied to CNN weights
that are being fine-tuned. This is because we already expect
that the weights are good, and we do not want to distort them
too much [25].
2) Data augmentation: Data augmentation is a technique
used where we do not have an infinite amount of data to
train our models. This can be done by introducing random
transformations to the data. In image classification, this can be
translated as rotating, flipping and cropping the image. These
perturbations add more variability to the input, thus this could
mean an overfitting reduction in our model by teaching it about
invariances in the data domain [28, 31, 32]. Therefore, these
transformations do not change the meaning of the input, thus,
the label originally attributed to it still holds its importance.
Although some transformations in an image can be done
agnostic to the field of application (e.g. translation), some
other transformations are entitled to domain-specific character-
istics. For this work we used an additional transformation that
randomizes the natural light effect in the picture, this was done
to mimic the transformations seen in indoors clinics due to
different light sources. Furthermore, to increase the variability
added by augmenting data, the probability of application and
magnitude variability are added to the transformations.
Have seen the needs for augmentation, it was used the
Augmentor Python library [33] for implementing the process
of augmenting the dataset. The library has predefined trans-
formations and has a hot-spot for new implementations of
transformations. This was quite useful when implementing the
method to add light variance to the augmentations.
Each transformation chosen to be applied had been based
on general guidelines of data augmentation [31, 32] or on the
nature of the data. Thus, the transformations were aligned in
a pipeline fashion, where each had a probability that defined
the likelihood of being applied to the image and at the end,
the new image was saved in the destination. Furthermore, the
operations used for this work were the ones listed in table III.
TABLE III: Transformations applied for data augmentation.
Transformation Probability
Rotation 0.5
Random zoom 0.4
Flip horizontally 0.7
Flip vertically 0.5
Random distortion 0.8
Lightning variance 0.5
C. Datasets Preparation
The first thing done, before applying transformations to the
dataset, was to separate a test set, usually a 10% to 20% of
each lesion, depending on the experiment. Following this, if
needed for the experiment, was done the data augmentation
process. Then the remaining sample was analyzed to see
how much was necessary to augment each class. The process
augmented the remaining dataset, usually, by a factor of 29
times. That summed with the original dataset was accounted
to 30 times the original amount.
After processing the images necessary to compose the
training and test datasets, the images for the training dataset
were processed to create an LMDB file [34] for fast access to
the data in training time. In this process the training dataset
is divided between a training set and a validation set. Thus,
this split is done in a way that 80% of the data is used for
training and 20% is for validation. However, this split is done
in a stratified way, so that each split has a fair amount of each
class.
Finally, these slices of the dataset are kept separated and
are used as such for the experiment.
D. Architecture
The architecture used for this work has been the ResNet-
152, used with pre-trained weights trained on ImageNet
database. This architecture was chosen mainly for the results
the family (ResNet-50, ResNet-101, and ResNet-152) had
achieved on other related works.
E. Metrics
The metrics used in the experiments were consistent
throughout this work. This decision was made to build the
ground necessary to compare the results between different
experiments. Therefore, two metrics were used in training time
and three for the testing step.
Training Time: For the training time, the main metric used
was the accuracy metric. Nonetheless, as the model classifies
12 classes, the accuracy reported has two variants: top-1
accuracy and top-5 accuracy (or accuracy@5).
Testing Step: For the testing step, it was created a process
that the predictions for both the validation and the test datasets
were generated. With these predictions in hand, as well as the
true labels of the examples, it was possible to create a con-
fusion matrix for the model. Furthermore, with the confusion
matrix at hand, was simple to compute other metrics, such as
precision, recall (or sensitivity), and accuracy as well.
Another metric used to evaluate the models was the AUC
(Area Under the Curve), along with the ROC (Receiver Op-
erating Characteristic) curve. The ROC curve is a mapping of
the sensitivity (probability of detection) versus 1−specificity
(probability of false alarm), using various thresholds points.
Typically, this metric is implemented in systems to analyze
how accurately the diagnosis of a patient state is (diseased
or healthy) [35]. Furthermore, the AUC summarizes the ROC
curve and effectively combines the specificity and the sensi-
tivity that describes the validity of the diagnosis [36].
Alongside with the ROC curve analysis, is common to
calculate the optimal cut-off point. This is used to further
separate the test results, so that a diagnosis of diseased or not
is provided. When the point is closest to where the sensitivity
is equal one and specificity is equal zero, it has achieved the
best result possible [37, 38].
F. Best Experiment
The best results achieved on this work were with the use
of the ResNet-152 architecture, trained over an augmented
dataset with a mixture of MED-NODE, Edinburgh and Atlas
datasets. The augmentation made was of 29 times for each
class, leaving the classes unbalanced.
Furthermore, the ResNet architecture had to be modified to
accommodate the needs of the problem at hand. So, the last
layer of the architecture was changed from 1,000 classes to
12 classes. Therefore, the final architecture produced followed
the same schema seen in Figure 2.
Moreover, the technique of transfer learning was applied to
generate the best results more rapidly. For that, the hyperpa-
rameters of the network had to be tuned and carefully set, for
that same purpose.
1) Dataset: The dataset used for the experiment was a
derivative of the previous experiment. The original dataset
consisted of a mixture of MED-NODE, Edinburgh and Atlas
images, moreover, the dataset did not go under augmentation
processes and was divided into three separated directories
following the division of 20%, 10%, and 70% for testing,
evaluation, and training, respectively.
Moreover, the training and validation datasets were aug-
mented, using the transformations listed in table III, by a
factor of 29 times. The testing dataset did not suffer any
transformations. Finally, the final numbers for the datasets can
be seen in table IV.
TABLE IV: Number of images used in the dataset for the final
experiment.
Number of images
Lesion Type Train Validation Test
Actinic Keratosis 742 186 8
Basal Cell Carcinoma 30,067 7,517 324
Dermatofibroma 1,067 267 12
Hemangioma 1,601 400 18
Intraepithelial Carcinoma 1,299 325 14
Lentigo 1,137 284 13
Malignant Melanoma 6,218 1,554 68
Melanocytic Nevus (mole) 17,632 4,408 191
Pyogenic Granuloma 371 93 5
Seborrheic Keratosis 19,256 4,814 208
Squamous Cell Carcinoma 1,462 365 16
Wart 7,238 1,810 79
TOTAL 88,090 22,023 956
2) Training: For the training phase, it was used transfer
learning techniques. Thus, it was necessary to gather the
ResNet-152 pre-trained weights for the ImageNet dataset3 first,
and then modify the network for the purpose of this work.
3Available at https://github.com/KaimingHe/deep-residual-networks. Last
accessed on June 26th, 2018.
TABLE V: Hyperparameters used.
Hyperparameter Value
base lr 0.01
weight decay 0.00001
momentum 0.9
gamma 0.1
batch size 5
max iter 176,180
test iter 22,023
test interval 2,000
stepsize 17,618
iter size 12
The learning rate was chosen to be higher than the used in
the related works, for two major factors. First of all, one of
the early experiments done showed that with a low learning
rate it was found a plateau on the very start of the training.
Thus, the network did not have the power to learn the features
of the skin lesions. Secondly, it was found that increasing the
learning rate often aids to reduce underfitting [39].
Additionally, the final dense layer has a 10 times factor
of multiplication for the learning rate, compared to the other
layers of the network. However, different from the process of
freezing the early layers, used in the same research, this work
approximates more to the approach implemented in [13], that
fine-tuned all the layers of the network.
This was done with the premise in mind, that although
the ImageNet dataset is far diverse and comprehends many
different objects, it does not have classes that approximate in
characteristics and problems encountered in this dataset of skin
lesions. Furthermore, it the weights in the early layers may not
be properly trained to extract fine features such as the ones
found within the problem that is faced in this work. Therefore,
it was needed to fine-tune the learnable parameters since the
early layers and learn the final classifier from scratch.
3) Hyperparameters: For this work it was used the Caffe
framework [40], since it allowed and simplified the changes
that were needed to do in the layer levels. Furthermore, all the
hyperparameters were defined in a separated configuration file
called “Solver”, necessary to define a .prototxt file with free
parameters used in the training. These hyperparameters can be
seen in table V.
Due to the infrastructure limitations it was only possible
to set the batch size to 5. However, the Caffe framework
provides an hyperparameter that serves as a hold on the update
of the gradients. The iter size defines how many iterations
the gradients will wait until the update. Altough using this
hyperparameter may affect the batch normalization layers used
in the architecture, the final results did not show this effect.
Furthermore, the maximum iteration parameter was chosen to
calculate the number of epochsto 10.
4) Infrastructure: All the experiments were conducted un-
der the same environment, that consisted of Antergos 18.3
(Linux kernel 4.16) running BVLC Caffe [40] with support
for an NVIDIA GTX 1070 GPU (Cuda 9.1 and cuDNN 7.1).
Fig. 2: ResNet-152 architecture used.
Source: Authors.
TABLE VI: Comparative between AUC metrics.
Lesion Esteva et al. Seog Han et al. This work
Actinic Keratosis - 0.83 0.96
Basal cell carcinoma - 0.90 0.91
Dermatofibroma - 0.90 0.90
Hemangioma - 0.83 0.99
Intraepithelial carcinoma - 0.83 0.99
Lentigo - 0.954 0.95
Malignant Melanoma 0.96 0.88 0.96
Melanocytic nevus - 0.94 0.95
Pyogenic granuloma - 0.97 0.99
Seborrheic keratosis - 0.89 0.90
Squamous cell carcinoma - 0.91 0.95
Wart - 0.944 0.89
IV. RESULTS
Finally, the model used in the testing phase was the product
of the iteration number 38,000. This training phase took
an uninterrupted total time of 35 hours (approximately 167
seconds for every 50 iterations).
A. Metric Results
With the confusion matrix generated for the predictions in
the testing dataset, was found that for all the 11 lesions, with
exception of the Actinic Keratosis, achieved a accuracy higher
than 80%. Thus accounting for a 78% total accuracy for the
model. However, this metric has a bias attached to it, since
the distribution of the classes is not even, and therefore can
cause misleading in the analysis of this metric.
Finally, the AUC and cut-off values for each ROC curve
have been calculated (Figure 3). The table VI shows a com-
parison between results in these three works.
B. Interpretability
For this work, it was judged to be important to bring an
input of the model‘s interpretability, since the application
is sensible with human life. Moreover, this work want to
raise the importance for the use of interpretability techniques
for machine learning in medical applications. In addition, an
model with an explainability may be more well received by
4Metric calculated with an Asian dataset, thus may not serve as a compar-
ative in a stricto sensu.
medical practitioners, since it demystify the decisions taken
by the model.
Moreover, model interpretability is important at several
points. For example, in the training phase if a model is behav-
ing unexpectedly an engineer must know what is happening
in order to reverse the situation. For that, if the engineer
has in hands the interpretability features of the data, it may
found out that the reasons to the behavior might be because
of a hindsight bias [41] present in the dataset. So, when
debugging an application that has a machine learning model,
it is important to have the tools to debug properly.
Another fact that is important to discuss is trust. When
people are using systems, specially life-critical systems such as
medical software, people want to trust that nothing unexpected
will happen. And trust for machine learning models can be
gained in two ways: through daily use evidence, that can be
achieved by getting a high accuracy, for example; another route
is to explain how did the model reach the decision, that in this
way the end-user will have not only proof that the decision
was correct, but how did it know it was a correct decision
to make. The second approach can lead to a scenario that
the “black-box” becomes less so, and less intimidating, thus
leading the user to be more inclining to use the prediction to
take action [42]. According to Gunning and DARPA (2016),
it is necessary to create a new approach to how the machine
learning models present their predictions.
1) Preliminary Results: An analysis of the model predic-
tions was made, as a way to discover which were the examples
in the validation dataset, that the model most got right and
wrong. This is used as an artifact for interpretability, since it
can bring new insights about the heuristics that are causing
the model‘s decisions. Additionally, it is also commonly used
even among simpler applications due to the simplicity of using
this technique.
Furthermore, the GradCAM technique [44] was applied for
this work, as a method to have visual feedback to where
the network‘s activations, previous to the softmax layer, were
more predominant. This gives more artifacts to build an
explanation for the model decisions. This can also be used to
identify problems where the network learns adjacent features
(a) Actinic Keratosis (b) Basal Cell Carci-
noma
(c) Dermatofibroma
(d) Haemangioma (e) Intrapithelial Car-
cinoma
(f) Lentigo
(g) Malignant
Melanoma
(h) Melanocytic Ne-
vus
(i) Pyogenic Granu-
loma
(j) Seborrhoeic Ker-
atosis
(k) Squamous Cell
Carcinoma
(l) Wart
Fig. 3: AUC and Optimal Cut-off for each lesion.
Source: Authors.
that may be present in lesion samples, but does not necessarily
hold meaning with the lesion (e.g. nails or hair in a scalp
near the lesion), vide the “Husky vs Wolf” experiment in
[45], where background snow was a predominant feature in
classifying a Wolf.
For the most wrong predictions, it was found that the causes
may fall under 2 factors: the lesion analyzed indeed caused
confusion between the lesions (Figure 4a); the model did not
generalize well and was struggling to extract predominant
features in some of the images, thus giving more importance
to areas that were not relevant, from a practical perspective
(Figure 4b and 4c).
The most correct lesions brought more information on what
(a) Predicted as Haemangioma with 100% confidence.
Source: Edinburgh dataset.
(b) Predicted as Basal Cell Carcinoma with 100% confidence.
Source: Edinburgh dataset.
(c) Predicted as Melanocytic Nevus with 97% confidence.
Source: MED-NODE dataset.
Fig. 4: GradCAM applied to the most wrong predictions for
Malignant Melanoma. Columns from left to right: original im-
age; original image fused with heat-map; heat-map produced
by GradCAM.
the model was already good at, and how this translate in a
perspective of image features. For example, in Figures 5a and
5b, the model found out that the regions that mostly identify
the lesions as Malignant Melanomas are indeed the ones that
would bring more relevance to the doctor‘s decision making
process. However there are still some examples, such as Figure
5c, that are more emblematic and need a expert‘s eye to shed
a light on it. Moreover, we can speculate that the model took
advantage of the geometric and color asymmetry in the lesion
to make an accurate decision.
Furthermore, it was found that the model generalizes well
for the examples that it was shown, correctly activating the
regions that contained the lesion, even in images that the pose
made challenging the localization of the lesion.
Nonetheless, this kind of interpretation is important not only
in a developer vision but also for the possible doctors that
were to receive a simple prediction and to take action on
another human life based on it. With these other tools, the
doctor has much more to support the next decision that is
necessary to take on the patient. Therefore, making the models
as interpretable as accurate can transform a tool in a good
counselor.
(a) Melanoma with 100% confidence.
Source: Edinburgh dataset.
(b) Melanoma with 100% confidence.
Source: Edinburgh dataset.
(c) Melanoma with 100% confidence.
Source: MED-NODE dataset.
Fig. 5: GradCAM applied to the most correct predictions for
Malignant Melanoma. Columns from left to right: original im-
age; original image fused with heat-map; heat-map produced
by GradCAM.
V. DISCUSSIONS
In this paper, we discussed the importance of automatic
classification method to support skin lesions diagnosis. Fur-
thermore, we listed a group of researches and their achieved
results for the same problem. However, it is still a problem
with several difficulties, even more when we study clinical
images, that may present an immense diversity due to variables
such as cameras and environments.
Seeing this, this work presented a model capable of clas-
sifying 12 skin lesions, that reached results comparable with
state-of-the-art. Additionally, it was presented studies on the
model decision taking process with interpretability techniques.
However, regardless of the excellent results encountered in
this work, it is necessary to further test the model with more
data, with more diversity (different ethnics and ages), and then
investigate the results for improvements.
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